These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7851609)

  • 1. Efficacy of flutamide versus spironolactone.
    Erenus M
    Fertil Steril; 1995 Mar; 63(3):680. PubMed ID: 7851609
    [No Abstract]   [Full Text] [Related]  

  • 2. Recurrence rate of hirsutism after 3 different antiandrogen therapies.
    Yücelten D; Erenus M; Gürbüz O; Durmuşoğlu F
    J Am Acad Dermatol; 1999 Jul; 41(1):64-8. PubMed ID: 10411413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone in the treatment of idiopathic hirsutism and the polycystic ovary syndrome.
    Evans DJ; Burke CW
    J R Soc Med; 1986 Aug; 79(8):451-3. PubMed ID: 3761287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial.
    Cusan L; Dupont A; Gomez JL; Tremblay RR; Labrie F
    Fertil Steril; 1994 Feb; 61(2):281-7. PubMed ID: 8299783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
    Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
    Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of hirsutism in HAIR-AN syndrome using flutamide, spironolactone, and birth control therapy.
    Zemtsov A; Wilson L
    Arch Dermatol; 1997 Apr; 133(4):431-3. PubMed ID: 9126004
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
    Taner C; Inal M; Başogul O; Onoglu A; Karanfil C; Tinar S; Ispahi C
    Gynecol Obstet Invest; 2002; 54(2):105-8. PubMed ID: 12566753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance of spironolactone.
    Hughes BR; Cunliffe WJ
    Br J Dermatol; 1988 May; 118(5):687-91. PubMed ID: 2969259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of sequential cyproterone acetate/estrogen versus spironolactone/oral contraceptive in the treatment of hirsutism.
    O'Brien RC; Cooper ME; Murray RM; Seeman E; Thomas AK; Jerums G
    J Clin Endocrinol Metab; 1991 May; 72(5):1008-13. PubMed ID: 1827125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of progestational activity of oral spironolactone.
    Nakajima ST; Brumsted JR; Riddick DH; Gibson M
    Fertil Steril; 1989 Jul; 52(1):155-8. PubMed ID: 2744183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hirsutism with spironolactone.
    Givens JR
    Fertil Steril; 1985 Jun; 43(6):841-3. PubMed ID: 3996628
    [No Abstract]   [Full Text] [Related]  

  • 14. Spironolactone and estrogen-progestin therapy for hirsutism.
    Board JA; Rosenberg SM; Smeltzer JS
    South Med J; 1987 Apr; 80(4):483-6. PubMed ID: 3563583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hirsutism with the pure antiandrogen flutamide.
    Cusan L; Dupont A; Bélanger A; Tremblay RR; Manhes G; Labrie F
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):462-9. PubMed ID: 2212145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can the anti-androgenic effect of spironolactone contraindicate its use in pregnancy?].
    Molinatti GM
    Minerva Ginecol; 1980 Apr; 32(4):239-40. PubMed ID: 7383427
    [No Abstract]   [Full Text] [Related]  

  • 17. Spironolactone in combination drug therapy for unresponsive hirsutism.
    Pittaway DE; Maxson WS; Wentz AC
    Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonist.
    Moghetti P; Castello R; Zamberlan N; Rossini M; Gatti D; Negri C; Tosi F; Muggeo M; Adami S
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1250-4. PubMed ID: 10199763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hirsutism.
    de Zegher F; Dunger DB; Ibáñez L
    N Engl J Med; 2006 Apr; 354(14):1533-5; author reply 1533-5. PubMed ID: 16602152
    [No Abstract]   [Full Text] [Related]  

  • 20. Hirsutes. II: Treatment.
    Young R; Sinclair R
    Australas J Dermatol; 1998 Aug; 39(3):151-7. PubMed ID: 9737040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.